Inventor · disambiguated record
Taraneh Mirzadegan
Also filed as: MIRZADEGAN TARANEH
10 granted patents·1 pending application·92 citations·filing 2001–2013
89Inventor score
Files withJANSSEN PHARMACEUTICA NV4ROCHE PALO ALTO LLC4KRAUSS NANCY E1ROCHEPALO ALTO LLC1SYNTEX LLC1
Top patents by PatentIndex Score
11 records- 0192US7189718B2Non-nucleoside reverse transcriptase inhibitorsROCHE PALO ALTO LLC·Filed 2004·Granted Mar 13, 2007·33 cites·40 claims
- 0287US9309222B2Phenyl linked quinolinyl modulators of RORγtJANSSEN PHARMACEUTICA NV·Filed 2013·Granted Apr 12, 2016·13 cites·25 claims
- 0384US7935725B2Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2008·Granted May 3, 2011·6 cites·16 claims
- 0481US8367719B2Aryl-substituted bridged or fused diamines as modulators of leukotriene A4 hydrolaseJANSSEN PHARMACEUTICA NV·Filed 2011·Granted Feb 5, 2013·5 cites·21 claims
- 0579US8344008B2Aryl-substituted bridged or fused diamines as modulators of leukotriene A ydrolaseJANSSEN PHARMACEUTICA NV·Filed 2011·Granted Jan 1, 2013·5 cites·4 claims
- 0676US6747053B2Heteroaryl nitrilesROCHE PALO ALTO LLC·Filed 2002·Granted Jun 8, 2004·10 cites·36 claims
- 0773US7241794B2Nonnucleoside reverse transcriptase inhibitorsROCHEPALO ALTO LLC·Filed 2004·Granted Jul 10, 2007·13 cites·5 claims
- 0872US6759428B2Indole nitrilesROCHE PALO ALTO LLC·Filed 2003·Granted Jul 6, 2004·5 cites·57 claims
- 0966US7388111B2Non-nucleoside reverse transcriptase inhibitorsROCHE PALO ALTO LLC·Filed 2006·Granted Jun 17, 2008·1 cites·15 claims
- 1063US7071177B2P-(sulfonyl) aryl and heteroarylamines as anti-inflammatory agentsSYNTEX LLC·Filed 2001·Granted Jul 4, 2006·1 cites·25 claims
- 1151US2006173075A1P-(sulfonyl) aryl and heteroarylamines-as anti-inflammatory agentsKRAUSS NANCY E·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Taraneh Mirzadegan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →